The ‘Accelerating Detection of Disease’ programme, announced by the UK Government this week, represents the largest study of its kind and is part of the biggest investment into UK research and development through the government’s modern Industrial Strategy.
Patient data will be used in combination with artificial intelligence (AI) to develop new diagnostic tests; the programme will recruit up to 5 million healthy people to volunteer data in order to facilitate the research and development of new methods for disease detection and prevention.
The aim of the programme is to be able to detect diseases before symptoms develop so patients can receive the highest quality care as early as possible. The early detection of disease and associated risk factors could revolutionise how healthcare is provided and offer improved outcomes regarding disease progression whilst also increasing the potential for disease prevention.
It is expected that up to £160 million will be co-invested by businesses and charities, with a further £79 million to be invested by the government to support research, early diagnosis, prevention and treatment for diseases including cancer, dementia and heart disease.
The business investment is a significant part of delivering the AI and Data Grand Challenge mission in which data and AI is used to innovate the prevention, early diagnosis and treatment of chronic diseases by 2030.
The programme is led by Professor Sir John Bell and brings together the NHS, industry and leading charities including Cancer Research UK, the British Heart Foundation and Alzheimer’s Research UK.
The full Government announcement can be found here.